246 related articles for article (PubMed ID: 8380735)
1. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
2. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
Abounader R; Laterra J
Neuro Oncol; 2005 Oct; 7(4):436-51. PubMed ID: 16212809
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
4. Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility.
Cutrupi S; Baldanzi G; Gramaglia D; Maffè A; Schaap D; Giraudo E; van Blitterswijk W; Bussolino F; Comoglio PM; Graziani A
EMBO J; 2000 Sep; 19(17):4614-22. PubMed ID: 10970854
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.
Wielenga VJ; van der Voort R; Taher TE; Smit L; Beuling EA; van Krimpen C; Spaargaren M; Pals ST
Am J Pathol; 2000 Nov; 157(5):1563-73. PubMed ID: 11073815
[TBL] [Abstract][Full Text] [Related]
6. Role of c-Met in cancer: emphasis on lung cancer.
Salgia R
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S52-8. PubMed ID: 19393836
[TBL] [Abstract][Full Text] [Related]
7. CD44 is required for two consecutive steps in HGF/c-Met signaling.
Orian-Rousseau V; Chen L; Sleeman JP; Herrlich P; Ponta H
Genes Dev; 2002 Dec; 16(23):3074-86. PubMed ID: 12464636
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
Schiering N; Knapp S; Marconi M; Flocco MM; Cui J; Perego R; Rusconi L; Cristiani C
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12654-9. PubMed ID: 14559966
[TBL] [Abstract][Full Text] [Related]
9. MET: a critical player in tumorigenesis and therapeutic target.
Graveel CR; Tolbert D; Vande Woude GF
Cold Spring Harb Perspect Biol; 2013 Jul; 5(7):. PubMed ID: 23818496
[TBL] [Abstract][Full Text] [Related]
10. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.
Zhang Y; Xia M; Jin K; Wang S; Wei H; Fan C; Wu Y; Li X; Li X; Li G; Zeng Z; Xiong W
Mol Cancer; 2018 Feb; 17(1):45. PubMed ID: 29455668
[TBL] [Abstract][Full Text] [Related]
11. A point mutation in the MET oncogene abrogates metastasis without affecting transformation.
Giordano S; Bardelli A; Zhen Z; Menard S; Ponzetto C; Comoglio PM
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13868-72. PubMed ID: 9391119
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF.
Hynds RE; Gowers KHC; Nigro E; Butler CR; Bonfanti P; Giangreco A; Prêle CM; Janes SM
PLoS One; 2018; 13(5):e0197129. PubMed ID: 29771943
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin.
Orian-Rousseau V; Morrison H; Matzke A; Kastilan T; Pace G; Herrlich P; Ponta H
Mol Biol Cell; 2007 Jan; 18(1):76-83. PubMed ID: 17065554
[TBL] [Abstract][Full Text] [Related]
14. Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B.
Tannoo RM; Richert L; Koschut D; Tomishige N; Treffert SM; Kobayashi T; Mély Y; Orian-Rousseau V
Biochim Biophys Acta Biomembr; 2024 Jan; 1866(1):184236. PubMed ID: 37793560
[TBL] [Abstract][Full Text] [Related]
15. MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling.
Liang Q; Hu Y; Yuan Q; Yu M; Wang H; Zhao B
Br J Cancer; 2024 Feb; 130(3):380-393. PubMed ID: 38110666
[TBL] [Abstract][Full Text] [Related]
16. Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling.
Woodard CL; Goodwin CR; Wan J; Xia S; Newman R; Hu J; Zhang J; Hayward SD; Qian J; Laterra J; Zhu H
PLoS One; 2013; 8(9):e72671. PubMed ID: 24023761
[TBL] [Abstract][Full Text] [Related]
17. Genetic targeting of the kinase activity of the Met receptor in cancer cells.
Arena S; Pisacane A; Mazzone M; Comoglio PM; Bardelli A
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11412-7. PubMed ID: 17595299
[TBL] [Abstract][Full Text] [Related]
18. Role of cMET in the development and progression of colorectal cancer.
Samamé Pérez-Vargas JC; Biondani P; Maggi C; Gariboldi M; Gloghini A; Inno A; Volpi CC; Gualeni AV; di Bartolomeo M; de Braud F; Castano A; Bossi I; Pietrantonio F
Int J Mol Sci; 2013 Sep; 14(9):18056-77. PubMed ID: 24005867
[TBL] [Abstract][Full Text] [Related]
19. Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.
Petrelli A; Circosta P; Granziero L; Mazzone M; Pisacane A; Fenoglio S; Comoglio PM; Giordano S
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5090-5. PubMed ID: 16547140
[TBL] [Abstract][Full Text] [Related]
20. The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth.
Luraghi P; Schelter F; Krüger A; Boccaccio C
Front Pharmacol; 2012; 3():164. PubMed ID: 22973229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
